195 related articles for article (PubMed ID: 2360804)
1. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?
Hirsch EC; Duyckaerts C; Javoy-Agid F; Hauw JJ; Agid Y
Ann Neurol; 1990 Jun; 27(6):676-82. PubMed ID: 2360804
[TBL] [Abstract][Full Text] [Related]
2. Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease.
Kordower JH; Cochran E; Penn RD; Goetz CG
Ann Neurol; 1991 Apr; 29(4):405-12. PubMed ID: 1681779
[TBL] [Abstract][Full Text] [Related]
3. Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease.
Hurtig H; Joyce J; Sladek JR; Trojanowski JQ
Ann Neurol; 1989 Jun; 25(6):607-14. PubMed ID: 2742361
[TBL] [Abstract][Full Text] [Related]
4. Bilateral recovery of striatal dopamine after unilateral adrenal grafting into the striatum of the 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-treated mouse.
Bohn MC; Kanuicki M
J Neurosci Res; 1990 Mar; 25(3):281-6. PubMed ID: 1969970
[TBL] [Abstract][Full Text] [Related]
5. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
6. [Cografts of adrenal medulla and peripheral nerve in a mouse model of Parkinson's disease].
Date I; Asari S; Nishimoto A; Felten D
No Shinkei Geka; 1991 Sep; 19(9):811-5. PubMed ID: 1944788
[TBL] [Abstract][Full Text] [Related]
7. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
[TBL] [Abstract][Full Text] [Related]
8. Adrenal to caudate transplantation--postmortem study.
Waters C; Itabashi HH; Apuzzo ML; Weiner LP
Mov Disord; 1990; 5(3):248-50. PubMed ID: 2388643
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.
Kordower JH; Goetz CG; Freeman TB; Olanow CW
Exp Neurol; 1997 Mar; 144(1):41-6. PubMed ID: 9126150
[TBL] [Abstract][Full Text] [Related]
10. [Adrenal medullary graft induces recovery of the host nigrostriatal dopaminergic system in MPTP-induced mouse model of Parkinson's disease].
Date I; Asari S; Nishimoto A; Felten DL
No To Shinkei; 1990 Dec; 42(12):1173-8. PubMed ID: 2083133
[TBL] [Abstract][Full Text] [Related]
11. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
Törnqvist N; Björklund L; Strömberg I
Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
[TBL] [Abstract][Full Text] [Related]
12. Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease.
Strada O; Hirsch EC; Javoy-Agid F; Duyckaerts C; Hauw JJ; Agid Y
J Neurol Sci; 1993 Dec; 120(1):33-7. PubMed ID: 8289077
[TBL] [Abstract][Full Text] [Related]
13. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft.
San Sebastián W; Guillén J; Manrique M; Belzunegui S; Ciordia E; Izal-Azcárate A; Garrido-Gil P; Vázquez-Claverie M; Luquin MR
Brain; 2007 May; 130(Pt 5):1306-16. PubMed ID: 17439984
[TBL] [Abstract][Full Text] [Related]
14. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease.
Madrazo I; Drucker-Colín R; Díaz V; Martínez-Mata J; Torres C; Becerril JJ
N Engl J Med; 1987 Apr; 316(14):831-4. PubMed ID: 3821826
[TBL] [Abstract][Full Text] [Related]
15. Catecholamines in CSF, plasma, and tissue after autologous transplantation of adrenal medulla to the brain in patients with Parkinson's disease.
Tyce GM; Ahlskog JE; Carmichael SW; Chritton SL; Stoddard SL; van Heerden JA; Yaksh TL; Kelly PJ
J Lab Clin Med; 1989 Aug; 114(2):185-92. PubMed ID: 2754305
[TBL] [Abstract][Full Text] [Related]
16. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.
Kish SJ; Shannak K; Hornykiewicz O
N Engl J Med; 1988 Apr; 318(14):876-80. PubMed ID: 3352672
[TBL] [Abstract][Full Text] [Related]
17. [Cografting technique in the treatment of Parkinson's disease].
Date I; Asari S; Nishimoto A; Felten D
No Shinkei Geka; 1991 Oct; 19(10):919-24. PubMed ID: 1944775
[TBL] [Abstract][Full Text] [Related]
18. Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case report.
Date I; Imaoka T; Miyoshi Y; Ono T; Asari S; Ohmoto T
J Neurosurg; 1996 Apr; 84(4):685-9. PubMed ID: 8613865
[TBL] [Abstract][Full Text] [Related]
19. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
20. Adrenal medulla in neural grafting and neural plasticity.
Hansen JT; Gash DM
Microsc Res Tech; 1994 Oct; 29(2):155-60. PubMed ID: 7812037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
